Abstract
Rapid emergence of drug resistant Human Immunodeficiency virus (HIV) variants and severe side effects of anti-HIV drugs limit the efficacy of existing anti-HIV therapies. Efforts are being made to develop newer anti-HIV agents. Few newer anti-HIV agents reached the different clinical phases of development and appear promising for future therapy. The present article highlights the current status of available anti-HIV drugs, emerging anti-HIV drug agents and recent anti-HIV drugs patents information.
Keywords: AIDS, antiretroviral drugs, clinical studies, emerging drugs, HIV, patents, NRTIs, zidovudine, Rilpivirine, Apricitabine
Recent Patents on Anti-Infective Drug Discovery
Title:Emerging Drugs for the Treatment of Human Immunodeficiency Virus
Volume: 7 Issue: 1
Author(s): Girish M. Bhopale
Affiliation:
Keywords: AIDS, antiretroviral drugs, clinical studies, emerging drugs, HIV, patents, NRTIs, zidovudine, Rilpivirine, Apricitabine
Abstract: Rapid emergence of drug resistant Human Immunodeficiency virus (HIV) variants and severe side effects of anti-HIV drugs limit the efficacy of existing anti-HIV therapies. Efforts are being made to develop newer anti-HIV agents. Few newer anti-HIV agents reached the different clinical phases of development and appear promising for future therapy. The present article highlights the current status of available anti-HIV drugs, emerging anti-HIV drug agents and recent anti-HIV drugs patents information.
Export Options
About this article
Cite this article as:
Girish M. Bhopale , Emerging Drugs for the Treatment of Human Immunodeficiency Virus , Recent Patents on Anti-Infective Drug Discovery 2012; 7 (1) . https://dx.doi.org/10.2174/157489112799829729
DOI https://dx.doi.org/10.2174/157489112799829729 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Advances in High-Field Magnetic Resonance Spectroscopy in Alzheimer’s Disease
Current Alzheimer Research Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Novel Immunotherapies for Hematological Malignancies
Current Molecular Pharmacology Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Immunization with Peptide-Protein Conjugates: Impact on Benchmarking B-Cell Epitope Prediction for Vaccine Design
Protein & Peptide Letters Current Status of Renal Arterial Endovascular Interventions
Current Hypertension Reviews Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine Anomalous Vascular Supply of Bronchial Circulation in Cystic Fibrosis Patients with Massive Hemoptysis
Current Respiratory Medicine Reviews The Role of a Disturbed Arginine/NO Metabolism in the Onset of Cancer Cachexia: A Working Hypothesis
Current Medicinal Chemistry Development of Novel Therapeutic Strategies for Lung Cancer: Targeting the Cholinergic System
Current Medicinal Chemistry Rallying the Troops: Innate Mucosal Responses to Enteric Pathogens
Current Immunology Reviews (Discontinued) The Therapeutic Potential of Targeting Autophagy in the Treatment of Cancer
Current Cancer Drug Targets Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Current Alzheimer Research The Immunomodulatory Effects of Physical Activity
Current Pharmaceutical Design Invertebrate Models of Kallmann Syndrome: Molecular Pathogenesis and New Disease Genes
Current Genomics Bacterial Toxins: Potential Weapons Against HIV Infection
Current Pharmaceutical Design Mast Cells At Mucosal Frontiers
Current Molecular Medicine Aldose Reductase: A Novel Target for Cardioprotective Interventions
Current Drug Targets Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS)
Current Pharmaceutical Design Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Anti-Cancer Agents in Medicinal Chemistry